# Cardiocycle

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardiocycle

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou Industrial Park, China
- Latest round: Series B (Aug 14, 2025)
- Investors on record: 3

## About

Founded in 2020 and based in Suzhou, China, Cardiocycle is an innovative medical device company co-founded by R&D and clinical experts, focusing on the R&D, manufacturing, and innovation of interventional medical devices. In August 2025, Cardiocycle raised a series B funding from new investors Tao Capital, Winfast Holding, and TF Capital. The company's products include structural heart disease and surgical accessories, as well as interventional vascular access products, forming one of the most comprehensive product portfolios and solutions for structural heart disease and vascular intervention in China. The company generates revenue by providing high-end medical device research and developme production.

## Funding rounds

- Series B, Aug 14, 2025 — TF Capital, Tao Capital, Winfast Holding

## Investors

- TF Capital — Series B
- Tao Capital (https://capitalatlas.ai/funds/tao-capital) — Series B
- Winfast Holding (https://capitalatlas.ai/funds/winfast-holding) — Series B